The expanding role of next-generation imaging in prostate cancer management: a cross-sectional survey exploring the clinical practice of uro-oncologists in North-Eastern Italy; on behalf of GUONE (Gruppo Uro-Oncologico del Nord-Est)

Authors: Fabio Matrone, Luca Urso, Rossano Girometti, Jerry Polesel, Matteo Sepulcri, Francesco Pierantoni, Paolo Artioli, Anna Caliò, Irene Campo, Alessia Cimadamore, Enrico Munari, Luca Ongaro, Valentina Orlando, Camilla Sachs, Alessandro Veccia, Alessandro Antonelli, Roberto Bortolus, Matteo Brunelli, Orazio Caffo, Laura Evangelista, Matteo Salgarello, Umberto Basso, Rocco De Vivo, Mario Gardi, Andrea Guttilla, Marco Andrea Signor, Fabio Zattoni, Filippo Alongi, Giampaolo Montesi, Gianluca Giannarini

Source: Therapeutic Advances in Urology, Vol 17 (2025)

Subject Terms: Diseases of the genitourinary system. Urology, RC870-923

File Description: electronic resource

Relation: https://doaj.org/toc/1756-2880

Access URL: https://doaj.org/article/a51b478cfff144f9a7551fa171aac215

Prognostic Value of G8 Geriatric Screening and Meet-URO Scores in Metastatic Renal Cell Carcinoma Patients Receiving First-Line Ipilimumab-Nivolumab Combination Immunotherapy

Authors: Ria Nagpal MB, BCh, BAO, Marina Campione PhD, Sara Elena Rebuzzi MD, Lucia Fratino MD, Pasquale Rescigno MD, Sergio Bracarda MD, Davide Bimbatti MD, Ugo De Giorgi MD, Matteo Santoni MD, Fabio Calabrò MD, Mimma Rizzo MD, Alessio Signori PhD, Diana Giannarelli PhD, Giuseppe Fornarini MD, Umberto Basso MD, Giuseppe Luigi Banna MD

Source: Technology in Cancer Research & Treatment, Vol 24 (2025)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1533-0338

Access URL: https://doaj.org/article/b990f85e877d4edba6164203ae896687

International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma – Meet-URO 33 study (REGAL study)

Authors: Sara Elena Rebuzzi, Giuseppe Fornarini, Alessio Signori, Sebastiano Buti, Giuseppe Procopio, Ugo De Giorgi, Sandro Pignata, Emanuele Naglieri, Marco Maruzzo, Giuseppe Luigi Banna, Pasquale Rescigno, Carlo Messina, Alvise Mattana, Umberto Basso, Davide Bimbatti

Source: BMC Cancer, Vol 24, Iss 1, Pp 1-5 (2024)

Subject Terms: Metastatic renal cell carcinoma, Immunotherapy, Immune checkpoint inhibitor, Clinical practice, Real-world, IMDC score, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2407

Access URL: https://doaj.org/article/07fb9d1891ed48f8877a4dc092e2bedf

Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study

Authors: Chiara Casadei, Emanuela Scarpi, Vincenza Conteduca, Giorgia Gurioli, Maria Concetta Cursano, Nicole Brighi, Cristian Lolli, Giuseppe Schepisi, Umberto Basso, Giuseppe Fornarini, Sara Bleve, Alberto Farolfi, Amelia Altavilla, Salvatore Luca Burgio, Emilio Francesco Giunta, Caterina Gianni, Alessia Filograna, Paola Ulivi, David Olmos, Elena Castro, Ugo De Giorgi

Source: European Urology Open Science, Vol 61, Iss , Pp 44-51 (2024)

Subject Terms: DNA damage repair gene mutations, Germline BRCA2 mutations, Metastatic prostate cancer, Precision medicine, Diseases of the genitourinary system. Urology, RC870-923, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S266616832400226X; https://doaj.org/toc/2666-1683

Access URL: https://doaj.org/article/da61ee9b940b4381ac3aa92030e5b551

Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective study

Authors: Lucia Fratino, Jerry Polesel, Emilio Francesco Giunta, Marco Maruzzo, Sebastiano Buti, Mona Ali Hassan, Umberto Basso, Sara Elena Rebuzzi, Ugo De Giorgi, Marika Cinausero, Helga Lipari, Teresa Gamba, Davide Bimbatti, Arianna Dri, Paola Ermacora, Francesca Vignani, Giuseppe Fornarini, Pasquale Rescigno, Giuseppe Luigi Banna

Source: Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: https://doaj.org/toc/2045-2322

Access URL: https://doaj.org/article/6a0ab27419da4917ac402a86c95934eb

A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study)

Authors: Pierangela Sepe, Giuseppe Procopio, Chiara Carlotta Pircher, Umberto Basso, Orazio Caffo, Vera Cappelletti, Melanie Claps, Ugo De Giorgi, Lucia Fratino, Valentina Guadalupi, Patrizia Miodini, Cinzia De Marco, Bruno Perrucci, Alessia Mennitto, Daniele Santini, Francesco Spina, Marco Stellato, Filippo de Braud, Elena Verzoni

Source: Therapeutic Advances in Medical Oncology, Vol 16 (2024)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1758-8359

Access URL: https://doaj.org/article/21ea7ba220ad4b319c9536d754e3134f

Robotic approach with neoadjuvant chemotherapy in adult Wilms’ tumor: A feasibility study report and a systematic review of the literature

Authors: Simone Sforza, Valeria Emma Palmieri, Maria Rosaria Raspollini, Giandomenico Roviello, Alberto Mantovani, Umberto Basso, Maria Carmen Affinita, Alberto D'Angelo, Lorenzo Antonuzzo, Marco Carini, Andrea Minervini, Lorenzo Masieri

Source: Asian Journal of Urology, Vol 10, Iss 2, Pp 128-136 (2023)

Subject Terms: Nephroblastoma, Nephrectomy, Renal neoplasm, Minimally invasive surgery, Rare tumor, Wilms' tumor, Diseases of the genitourinary system. Urology, RC870-923

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2214388222000340; https://doaj.org/toc/2214-3882

Access URL: https://doaj.org/article/ae3c61dafd894ae29733aebe7a2ff9ee

Renal cell carcinoma: the population, real world, and cost-of-illness

Authors: Alessandra Buja, Giuseppe De Luca, Maura Gatti, Claudia Cozzolino, Massimo Rugge, Manuel Zorzi, Mario Gardi, Matteo Sepulcri, Davide Bimbatti, Vincenzo Baldo, Marco Maruzzo, Umberto Basso, Vittorina Zagonel

Source: BMC Urology, Vol 22, Iss 1, Pp 1-8 (2022)

Subject Terms: Renal cell carcinoma, Cost-of-illness, Economic impact, Real-world data, Diseases of the genitourinary system. Urology, RC870-923

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2490

Access URL: https://doaj.org/article/b7c0b6dfeb9a4ee5ad0ad00faec961ee

The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network

Authors: Giuseppe Luigi Banna, Umberto Basso, Emilio Francesco Giunta, Lucia Fratino, Sara Elena Rebuzzi, Sebastiano Buti, Marco Maruzzo, Ugo De Giorgi, Veronica Murianni, Marika Cinausero, Helga Lipari, Teresa Gamba, Orazio Caffo, Davide Bimbatti, Arianna Dri, Alessandra Mosca, Paola Ermacora, Francesca Vignani, Aichi Msaki, Barbara Bonifacio, Valentina Lombardo, Vincenza Conteduca, Giuseppe Fornarini, Pasquale Rescigno

Source: Current Oncology, Vol 29, Iss 10, Pp 7745-7753 (2022)

Subject Terms: G8 score, geriatric assessment, adherence to treatment, prostate cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.mdpi.com/1718-7729/29/10/612; https://doaj.org/toc/1198-0052; https://doaj.org/toc/1718-7729

Access URL: https://doaj.org/article/9af65c31e22e4c4daa86343bb2d1ded2

Corrigendum: Impressive reduction of brain metastasis radionecrosis after cabozantinib therapy in metastatic renal carcinoma: a case report and review of the literature

Authors: Jacopo Lolli, Francesca Tessari, Franco Berti, Marco Fusella, Davide Fiorentin, Davide Bimbatti, Umberto Basso, Fabio Busato

Source: Frontiers in Oncology, Vol 13 (2023)

Subject Terms: cabozantinib, radionecrosis (RN), stereotacic radiation, immunotherapy, radiosurgery, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2023.1278074/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/a6b59fb4c5e14aa4b7dd6537ffce6ec6

Prognostic role of systemic inflammation indexes in metastatic urothelial carcinoma treated with immunotherapy

Authors: Michele Dionese, Umberto Basso, Francesco Pierantoni, Eleonora Lai, Nicolò Cavasin, Elisa Erbetta, Salim Jubran, Giorgio Bonomi, Davide Bimbatti, Marco Maruzzo

Source: Future Science OA, Vol 9, Iss 7 (2023)

Subject Terms: bladder carcinoma, immune-related adverse events, immunotherapy, neutrophil-to-lymphocyte ratio, urothelial carcinoma, Medicine, Medicine (General), R5-920

File Description: electronic resource

Relation: https://doaj.org/toc/2056-5623

Access URL: https://doaj.org/article/e7a92d8288ff47c9829ad4d408f11ea4

The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study

Authors: Sara Elena Rebuzzi, Alessio Signori, Giuseppe Luigi Banna, Annalice Gandini, Giuseppe Fornarini, Alessandra Damassi, Marco Maruzzo, Ugo De Giorgi, Umberto Basso, Silvia Chiellino, Luca Galli, Paolo Andrea Zucali, Emanuela Fantinel, Emanuele Naglieri, Giuseppe Procopio, Michele Milella, Francesco Boccardo, Lucia Fratino, Stefania Pipitone, Riccardo Ricotta, Stefano Panni, Veronica Mollica, Mariella Sorarù, Matteo Santoni, Alessio Cortellini, Veronica Prati, Hector Josè Soto Parra, Daniele Santini, Francesco Atzori, Marilena Di Napoli, Orazio Caffo, Marco Messina, Franco Morelli, Giuseppe Prati, Franco Nolè, Francesca Vignani, Alessia Cavo, Giandomenico Roviello, Pasquale Rescigno, Sebastiano Buti

Source: Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-7 (2022)

Subject Terms: Metastatic renal cell carcinoma, Nephrectomy, Immunotherapy, Nivolumab, Prognostic, Meet URO score, Medicine

File Description: electronic resource

Relation: https://doaj.org/toc/1479-5876

Access URL: https://doaj.org/article/5d27a41c30724b90858c7fbb9dde10ad

Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet‐Uro 19BEYOND study

Authors: Giandomenico Roviello, Elisabetta Gambale, Roberta Giorgione, Daniele Santini, Marco Stellato, Giuseppe Fornarini, Sara Elena Rebuzzi, Umberto Basso, Davide Bimbatti, Laura Doni, Gabriella Nesi, Melissa Bersanelli, Sebastiano Buti, Ugo De Giorgi, Luca Galli, Andrea Sbrana, Raffaele Conca, Claudia Carella, Emanuele Naglieri, Sandro Pignata, Giuseppe Procopio, Lorenzo Antonuzzo

Source: Cancer Medicine, Vol 11, Iss 16, Pp 3084-3092 (2022)

Subject Terms: fourth‐line therapy, immune checkpoint inhibitors, metastatic renal cell carcinoma, targeted therapy, tyrosine kinase inhibitors, vascular endothelial growth factor receptor, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2045-7634

Access URL: https://doaj.org/article/5c1b0d246d484bad81a6a45b350d5ccd

Circulating tumor cell gene expression and plasma AR gene copy number as biomarkers for castration-resistant prostate cancer patients treated with cabazitaxel

Authors: Giorgia Gurioli, Vincenza Conteduca, Nicole Brighi, Emanuela Scarpi, Umberto Basso, Giuseppe Fornarini, Alessandra Mosca, Maurizio Nicodemo, Giuseppe Luigi Banna, Cristian Lolli, Giuseppe Schepisi, Giorgia Ravaglia, Isabella Bondi, Paola Ulivi, Ugo De Giorgi

Source: BMC Medicine, Vol 20, Iss 1, Pp 1-13 (2022)

Subject Terms: mCRPC, Cabazitaxel, AR-V7, AR copy number, CTC, Medicine

File Description: electronic resource

Relation: https://doaj.org/toc/1741-7015

Access URL: https://doaj.org/article/d29eb01c551a427fb416b8fbeaed9d19

Impressive reduction of brain metastasis radionecrosis after cabozantinib therapy in metastatic renal carcinoma: A case report and review of the literature

Authors: Jacopo Lolli, Francesca Tessari, Franco Berti, Marco Fusella, Davide Fiorentin, Davide Bimbatti, Umberto Basso, Fabio Busato

Source: Frontiers in Oncology, Vol 13 (2023)

Subject Terms: cabozantinib, radionecrosis (RN), stereotacic radiation, immunotherapy, radiosurgery, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2023.1136300/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/022f880afaed409e9dcd7f8631cc9873

Nivolumab drug holiday in patients treated for metastatic renal cell carcinoma: A real-world, single-centre experience

Authors: Davide Bimbatti, Michele Dionese, Eleonora Lai, Nicolò Cavasin, Umberto Basso, Alvise Mattana, Francesco Pierantoni, Vittorina Zagonel, Marco Maruzzo

Source: Frontiers in Oncology, Vol 12 (2022)

Subject Terms: mRCC, renal cell carcinoma, anti-PD1, immunotherapy, rechallenge, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2022.960751/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/e7c9bff5d3e444d686cbd29b7d26c867

Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib

Authors: Sara Elena Rebuzzi, Luigi Cerbone, Alessio Signori, Matteo Santoni, Veronica Murianni, Ugo De Giorgi, Giuseppe Procopio, Camillo Porta, Michele Milella, Umberto Basso, Francesco Massari, Marco Maruzzo, Roberto Iacovelli, Nicola Battelli, Luca Carmisciano, Giuseppe Luigi Banna, Sebastiano Buti, Giuseppe Fornarini

Source: Therapeutic Advances in Medical Oncology, Vol 14 (2022)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1758-8359

Access URL: https://doaj.org/article/e61b5567e94341248f175a705d2cf564

Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14)

Authors: Marco Maruzzo, Elena Verzoni, Maria Giuseppa Vitale, Michele Dionese, Sebastiano Buti, Luca Galli, Andrea Zivi, Sara Watutantrige-Fernando, Teresa Zielli, Elisa Zanardi, Roberto Sabbatini, Umberto Basso, Vittorina Zagonel, Giuseppe Procopio

Source: Frontiers in Oncology, Vol 11 (2021)

Subject Terms: renal cell carcinoma, FT3/FT4, deiodination, tyrosine kinase inhibitors, immunotherapy, progression, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2021.787835/full; https://doaj.org/toc/2234-943X

Access URL: https://doaj.org/article/9a3e4a93738845bf87bc0203274f79b2

Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results

Authors: Gaetano Facchini, Sabrina Rossetti, Massimiliano Berretta, Carla Cavaliere, Sarah Scagliarini, Maria Giuseppa Vitale, Chiara Ciccarese, Giuseppe Di Lorenzo, Erica Palesandro, Vincenza Conteduca, Umberto Basso, Emanuele Naglieri, Azzurra Farnesi, Michele Aieta, Nicolò Borsellino, Leonardo La Torre, Gelsomina Iovane, Lucia Bonomi, Donatello Gasparro, Enrico Ricevuto, Michele De Tursi, Rocco De Vivo, Giovanni Lo Re, Francesco Grillone, Paolo Marchetti, Ferdinando De Vita, Claudio Scavelli, Claudio Sini, Salvatore Pisconti, Anna Crispo, Vittorio Gebbia, Antonio Maestri, Luca Galli, Ugo De Giorgi, Roberto Iacovelli, Carlo Buonerba, Giacomo Cartenì, Carmine D’Aniello

Source: Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-11 (2019)

Subject Terms: Axitinib, Sunitinib, Metastatic, Renal cancer, Treatment, Medicine

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s12967-019-2047-4; https://doaj.org/toc/1479-5876

Access URL: https://doaj.org/article/ce45764abe174be68515afe7c66b3135

Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study)

Authors: Melissa Bersanelli, Sebastiano Buti, Alessio Cortellini, Marco Bandini, Giuseppe Luigi Banna, Filippo Pederzoli, Elena Farè, Daniele Raggi, Patrizia Giannatempo, Ugo De Giorgi, Umberto Basso, Tania Losanno, Daniele Santini, Claudia Mucciarini, Marcello Tucci, Rosa Tambaro, Azzurra Farnesi, Orazio Caffo, Antonello Veccia, Emanuele Naglieri, Alberto Briganti, Giuseppe Procopio, Sandro Pignata, Andrea Necchi

Source: Clinical Medicine Insights: Oncology, Vol 15 (2021)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/1179-5549

Access URL: https://doaj.org/article/5987142a35614d8f8862429246a6e6f1